Local News Research Suggests New Therapeutic Target for Kidney DiseasesBU School of Medicine | May 6, 2020Researchers have published a new study that suggests a signaling pathway called ROBO2 is a…eabramovichMay 6, 2020 Read More
Local News Boston Children’s Hospital to Lead Nationwide Study on COVID-19 in ChildrenBoston Children's Hospital | May 5, 2020Why are children largely spared from COVID-19 — and why do a tiny handful become extremely…eabramovichMay 5, 2020 Read More
Local News Harvard’s Wyss Institute Joins Forces with Cytosurge to Improve CRISPR-Based Multiplexed Gene EditingWyss Institute | May 5, 2020Today, the Wyss Institute for Biologically Inspired Engineering at Harvard University and Cytosurge AG, a company…eabramovichMay 5, 2020 Read More
Local News Optogenetics with SOULMcGovern Institute | May 4, 2020Optogenetics has revolutionized neurobiology, allowing researchers to use light to activate or deactivate neurons that are…eabramovichMay 4, 2020 Read More
Local News CRISPR-Based Diagnostic Chips Perform Thousands of Tests Simultaneously to Detect VirusesMIT News | May 4, 2020Researchers have developed a new technology that flexibly scales up CRISPR-based molecular diagnostics, using microfluidics…eabramovichMay 4, 2020 Read More
Local News Immune System Changes Occur Early in Development of Multiple MyelomaBroad Institute | May 1, 2020Long before multiple myeloma becomes a malignant disease, the collection of immune system cells and…eabramovichMay 1, 2020 Read More
Local News “Backpacks” Boost Immune Cells’ Ability to Kill CancerWyss Institute | May 1, 2020Macrophages are immune cells that patrol the body looking for potential threats like viruses, bacteria,…eabramovichMay 1, 2020 Read More
Local News Soup to Nuts: Church Lab Tackles the New Coronavirus from Multiple DirectionsWyss Institute | April 30, 2020The COVID-19 pandemic demands action on many fronts, from prevention to testing to treatment. Not content…eabramovichApril 30, 2020 Read More
Local News New Targeted Agent Produces Considerable Responses in Trial with Patients with Uterine Serous CarcinomaDana-Farber | April 30, 2020In its first clinical trial in patients with a hard-to-treat form of uterine cancer, a…eabramovichApril 30, 2020 Read More
Local News Rome Therapeutics Debuts with $50M and Rosana Kapeller at the HelmFierce Biotech | April 29, 2020In 2018, Rosana Kapeller left Nimbus Therapeutics, the company she built from the ground up,…eabramovichApril 29, 2020 Read More